🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥

News

Pods

Back

Rishu
•

Medial • 2m

Re-thinking Cancer Treatment: A Hundred Million Steps Forward Cancer impacts more than 19 million people worldwide annually, yet breakthroughs in treatment remain a critical need. Umoja Biopharma, a six year old Seattle-based biotech startup that’s tackling this challenge head-on with a game-changing approach. Umoja just raised $100 million in Series C funding to advance their in vivo CAR T-cell therapy, an innovative treatment designed to train the patient’s own body to generate cancer-fighting cells. This approach could redefine the oncology landscape, potentially reducing costs, improving accessibility, and saving countless lives. This round of funding was co-led by Double Point Ventures and DCVC Bio, alongside notable contributions from ARK Investment Management LLC, SoftBank, Alexandria Venture Investments , and others signalling a strong vote of confidence in Umoja’s vision. For context, the global CAR T-cell therapy market is expected to grow at a CAGR of 34.5%, reaching $20 billion by 2030. Umoja’s research could play a pivotal role in shaping this future. This isn’t just about investment or venture capital but reshaping the fight against cancer.

6 replies14 likes

Replies (6)

Kesav Bihani

Hey I am on Medial • 2m

Are they available in India? If it is successful, then they will be having great business. Thanks for sharing.

0 replies2 likes

Suman Meghwal

Wealthseeker • 2m

bro that's great , hats off to the research of the company and efforts they pay . but may be for the people who also have to understand who are not effected yet , take Nature therapy may be it helps , like now I started playing games , and sit in nature , and this all helps , there also too many natural frutis which helps also In fighting against cancer .

0 replies1 like

Anonymous 3

Hey I am on Medial • 2m

The real breakthrough isn't just the treatment itself - it's the potential democratization of CAR T-cell therapy. Current treatments require sophisticated facilities and can cost upwards of $500k. If Umoja succeeds, we could see treatment centers in smaller hospitals, not just major medical centers. That's worth celebrating regardless of the investment details

0 replies

SamCtrlPlusAltMan
•

OpenAI • 2m

🔥

0 replies

Anonymous 2

Hey I am on Medial • 2m

Classic venture capital hype machine at work. Remember all those flashy biotech startups that promised to 'revolutionize' cancer treatment? $100 million is pocket change compared to what Big Pharma spends on R&D. Wake me up when they have Phase 3 results. Until then, this is just another Silicon Valley pipe dream trying to disrupt healthcare without understanding its complexity

0 replies

Anonymous 1

Hey I am on Medial • 2m

💯💯

0 replies

Recommendations from Medial

Vishu Bheda
•

Medial • 5m

Billionaires aren't just chasing money anymore. They're buying time. I found the 5 most popular high-end treatments of the ultra-wealthy. This is how the 0.1% plan to live to 150 (or beyond): 1. Blood Plasma Transfusions This treatment involves

10 replies25 likes

Dev Prakash Pandey

Learner || Content W... • 7m

World-First Lung Cancer Vaccine Trials Launched. According to reports from multiple sources, UK has become the first to receive an innovative lung cancer vaccine. Developed by researchers, the vaccine is designed to stimulate the immune system to t

0 replies4 likes

Anonymous

Hey I am on Medial • 7m

It's official—the first patient has received the lung cancer vaccine. 💉 The vaccine, BNT116, is not chemotherapy. It's a targeted treatment that attacks only cancer cells, leaving healthy cells unharmed. 🎯 Next in line are 130 patients across 7 co

4 replies5 likes

Poosarla Sai Karthik

Tech guy with a busi... • 25d

Most AI mental health apps today claim to replace real therapists, but there’s a major flaw—they don’t consider a person’s past therapy records. They just simulate conversations based on what the user says at that moment, without understanding their

0 replies2 likes

SamCtrlPlusAltMan
•

OpenAI • 5d

New York-based Jones, founded by Hilary Dubin and Caroline Vasquez Huber, raised a $10 million Series A round led by Foundry, valuing the nicotine lozenge startup at around $45 million. Jones aims to modernize nicotine replacement therapy with a styl

3 replies16 likes

Shuvodip Ray
•

YouTube • 10m

Digital fitness and wellness technology startup Portl has raised $3 million in a new round led by Bharat Innovation Fund. This round also saw participation from existing investor Kalaari Capital and new investor T-Hub Foundation.

4 replies5 likes

Account Deleted

Hey I am on Medial • 19d

How to convert normal car into an E car, is there anyone in this market? Will you buy such a device?

yes

Votes: 13

1 replies4 likes

Havish Gupta

Figuring Out • 9m

Finding parking spots in metro cities is very challenging. Even Amit Lakhotia, former VP at Paytm, faced this issue. He sometimes had meetings scheduled at 10, and struggled to find parking at 9:50. Frustrated, he started Park+, which suggests emp

27 replies17 likes

Loot Instaa

Hey I am on Medial • 1y

Do you things this can create revolution change in india "A watch which do not require cell it run on human body electricity "

7 replies16 likes

Shubham Khandelwal

Data Science Enthusi... • 9m

15 Crores ($1.7 Million) for a 4 BHK flat in Noida, UP. That's insanely overpriced. Does India's Real Estate market is in a Bubble? For this kind of money you can buy a property in a decent location in Dubai or Singapore. Tweet Link: https://x.com/